Skip to main content

HealthTimes

Global Health HIV/AIDS

FDA Approves Dolutegravir Tablets for Oral Suspension for Children With HIV

Michael Gwarisa

OFFICIALS with the FDA have approved dolutegravir (Tivicay PD, ViiV Healthcare) dispersible tablets for oral suspension for children who are at least 4 weeks of age and weigh at least 3 kg, according to a press release. SOURCE: DRUG TOPICS This approval marks the first ever dispersible tablet formulation of dolutegravir, which are used in

Read More
Dr Grant Murewanhema
Features OP ED

#Talking COVID-19 With Dr Grant: Are We Doing Enough Testing For COVID-19 In Zimbabwe?

Michael Gwarisa

THE first cases of COVID-19 were confirmed in Wuhan, China,  in December 2019, and a few months later the disease became a worldwide pandemic. To date over 7 million infections have been reported. Zimbabwe has reported 356 cases, which include 4 deaths and 54 recoveries. By Grant Murewanhema Transmission patterns include imported disease, sporadic disease,

Read More
Features Opinion

Open letter to the Minister of Health From Quarantine

Michael Gwarisa

AFTER spending 22 days in captivity we were told that we cannot leave quarantine after testing. The standard published by the government is a maximum of 21, but I am sitting at 25 with cellmates having up to 30 and even more. The reason behind our continued detention being: of the over 100 tests conducted

Read More